OncoZenge AB (publ) (STO:ONCOZ)
Sweden
· Delayed Price · Currency is SEK 6.38
+0.21 (3.40%)
Apr 29, 2026, 3:48 PM CET
OncoZenge AB Market Cap
OncoZenge AB has a market cap or net worth of 86.68 million as of April 29, 2026. Its market cap has increased by 65.36% in one year.
Market Cap
86.68M
Enterprise Value
90.46M
Revenue
2.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.38
Market Cap Chart
Since February 12, 2021, OncoZenge AB's market cap has decreased from 89.02M to 86.68M, a decrease of -2.63%. That is a compound annual growth rate of -0.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 86.68M | 1.38% |
| Dec 30, 2025 | 85.49M | 94.64% |
| Dec 30, 2024 | 43.92M | 21.36% |
| Dec 29, 2023 | 36.19M | -43.82% |
| Dec 30, 2022 | 64.42M | -52.42% |
| Dec 30, 2021 | 135.41M | 52.11% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AcouSort AB | 82.12M |
| Spago Nanomedical AB | 80.38M |
| Pila Pharma AB | 73.32M |
| Nanologica AB | 72.46M |
| Biovica International AB | 93.12M |
| Alzinova AB | 70.35M |
| Magle Chemoswed Holding AB | 97.05M |
| Scandinavian ChemoTech AB | 99.02M |